Advertisement
Screener

MILESTONE SCIENTIFIC INC. (MLSS) Royalty Expense

MILESTONE SCIENTIFIC INC. Royalty Expense

MILESTONE SCIENTIFIC INC. (MLSS) reported Royalty Expense of $119.78 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:RoyaltyExpense · last filed 2025-08-14

  • MILESTONE SCIENTIFIC INC. royalty expense for the quarter ending 2025-06-30 was $119.78K, a 26.15% increase year-over-year.
  • MILESTONE SCIENTIFIC INC. royalty expense for the quarter ending 2025-03-31 was $112.49K, a 2.77% decline year-over-year.
  • MILESTONE SCIENTIFIC INC. royalty expense for the quarter ending 2024-06-30 was $94.95K.
  • MILESTONE SCIENTIFIC INC. royalty expense for the quarter ending 2024-03-31 was $115.69K.
  • MILESTONE SCIENTIFIC INC. royalty expense for fiscal 2024 was $442.06K, a 8.92% decline from fiscal 2023.
  • MILESTONE SCIENTIFIC INC. royalty expense for fiscal 2023 was $485.33K.
Period endRoyalty Expense 3 monthRoyalty Expense 6 monthRoyalty Expense 12 month
2025-06-30$119.78K
10-Q · filed 2025-08-14
$232.27K
10-Q · filed 2025-08-14
2025-03-31$112.49K
10-Q · filed 2025-05-15
2024-12-31$442.06K
10-K · filed 2025-04-15
2024-06-30$94.95K
10-Q · filed 2025-08-14
$210.64K
10-Q · filed 2025-08-14
2024-03-31$115.69K
10-Q · filed 2025-05-15
2023-12-31$485.33K
10-K · filed 2025-04-15
2018-06-30$116.96K
10-Q · filed 2018-08-14
$202.48K
10-Q · filed 2018-08-14
2017-06-30$123.76K
10-Q · filed 2018-08-14
$305.67K
10-Q · filed 2018-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lifeward Ltd. (LFWD)$0.021B
ALPHA PRO TECH LTD (APT)$0.052B13.63
Envoy Medical, Inc. (COCH)United States$0.056B
ENvue Medical, Inc. (FEED)United States$0.011B
MYOMO, INC. (MYO)United States$0.065B-2.85
Bone Biologics Corp (BBLG)United States$0.001B
LogicMark, Inc. (LGMK)United States$0.000B
Safe Pro Group Inc. (SPAI)United States$0.090B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
NutriBand Inc. (NTRB)United States$0.109B